カテゴリー： QYResearch, 世界, 医療/バイオ

世界の医療用3Dバイオプリンティング市場インサイト及び予測（SLA、FDM、LOM、その他）

◆英語タイトル：Global Medical 3D Bioprinting Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09698）◆商品コード：QY22JLX09698
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：128
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、医療用3Dバイオプリンティングのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用3Dバイオプリンティングの世界市場のxxx％を占める「SLA」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「医療機器メーカー」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
医療用3Dバイオプリンティングの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの医療用3Dバイオプリンティング市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

医療用3Dバイオプリンティングのグローバル主要企業には、3D Systems、GE Healthcare、ExOne、Electro Optical Systems、Renishaw、Stratasys、EnvisionTEC、Cyfuse Biomedical、Formlabs、Organovo Holdings、Allevi、Advanced Solutions、Aspect Biosystems、CELLINK、GeSiM、Bio3D Technologies、Regenovo Biotechnology、Optomec、Mecuris、Fluicell、BigRepなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

医療用3Dバイオプリンティング市場は、種類と用途によって区分されます。世界の医療用3Dバイオプリンティング市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
SLA、FDM、LOM、その他

【用途別セグメント】
医療機器メーカー、製薬企業、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 医療用3Dバイオプリンティング製品概要
- 種類別市場（SLA、FDM、LOM、その他）
- 用途別市場（医療機器メーカー、製薬企業、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の医療用3Dバイオプリンティング販売量予測2017-2028
- 世界の医療用3Dバイオプリンティング売上予測2017-2028
- 医療用3Dバイオプリンティングの地域別販売量
- 医療用3Dバイオプリンティングの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別医療用3Dバイオプリンティング販売量
- 主要メーカー別医療用3Dバイオプリンティング売上
- 主要メーカー別医療用3Dバイオプリンティング価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（SLA、FDM、LOM、その他）
- 医療用3Dバイオプリンティングの種類別販売量
- 医療用3Dバイオプリンティングの種類別売上
- 医療用3Dバイオプリンティングの種類別価格
・用途別市場規模（医療機器メーカー、製薬企業、その他）
- 医療用3Dバイオプリンティングの用途別販売量
- 医療用3Dバイオプリンティングの用途別売上
- 医療用3Dバイオプリンティングの用途別価格
・北米市場
- 北米の医療用3Dバイオプリンティング市場規模（種類別、用途別）
- 主要国別の医療用3Dバイオプリンティング市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの医療用3Dバイオプリンティング市場規模（種類別、用途別）
- 主要国別の医療用3Dバイオプリンティング市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の医療用3Dバイオプリンティング市場規模（種類別、用途別）
- 主要国別の医療用3Dバイオプリンティング市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の医療用3Dバイオプリンティング市場規模（種類別、用途別）
- 主要国別の医療用3Dバイオプリンティング市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの医療用3Dバイオプリンティング市場規模（種類別、用途別）
- 主要国別の医療用3Dバイオプリンティング市場規模（トルコ、サウジアラビア）
・企業情報
3D Systems、GE Healthcare、ExOne、Electro Optical Systems、Renishaw、Stratasys、EnvisionTEC、Cyfuse Biomedical、Formlabs、Organovo Holdings、Allevi、Advanced Solutions、Aspect Biosystems、CELLINK、GeSiM、Bio3D Technologies、Regenovo Biotechnology、Optomec、Mecuris、Fluicell、BigRep
・産業チェーン及び販売チャネル分析
- 医療用3Dバイオプリンティングの産業チェーン分析
- 医療用3Dバイオプリンティングの原材料
- 医療用3Dバイオプリンティングの生産プロセス
- 医療用3Dバイオプリンティングの販売及びマーケティング
- 医療用3Dバイオプリンティングの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 医療用3Dバイオプリンティングの産業動向
- 医療用3Dバイオプリンティングのマーケットドライバー
- 医療用3Dバイオプリンティングの課題
- 医療用3Dバイオプリンティングの阻害要因
・主な調査結果

Medical 3D bioprinting is the use of 3D printing-like techniques to combine cells, growth factors or biological materials to create biomedical parts, often with the aim of mimicking natural tissue characteristics. In general, 3D bioprinting can utilize a layer-by-layer approach to deposit materials called bioinks to create tissue-like structures that are subsequently used in various fields of medicine and tissue engineering. Bioprinting covers a wide range of bioprinting techniques and biomaterials. Currently, bioprinting can be used to print tissue and organ models to aid in the study of drugs and potential treatments.
Market Analysis and Insights: Global Medical 3D Bioprinting Market
The global Medical 3D Bioprinting market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, SLA accounting for % of the Medical 3D Bioprinting global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Medical Device Manufacturers segment is altered to an % CAGR throughout this forecast period.
China Medical 3D Bioprinting market size is valued at US$ million in 2021, while the North America and Europe Medical 3D Bioprinting are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Medical 3D Bioprinting landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Medical 3D Bioprinting market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Medical 3D Bioprinting market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Medical 3D Bioprinting market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Medical 3D Bioprinting market.
Global Medical 3D Bioprinting Scope and Market Size
Medical 3D Bioprinting market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Medical 3D Bioprinting market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
SLA
FDM
LOM
Others
Segment by Application
Medical Device Manufacturers
Pharmaceutical Companies
Others
By Company
3D Systems
GE Healthcare
ExOne
Electro Optical Systems
Renishaw
Stratasys
EnvisionTEC
Cyfuse Biomedical
Formlabs
Organovo Holdings
Allevi
Advanced Solutions
Aspect Biosystems
CELLINK
GeSiM
Bio3D Technologies
Regenovo Biotechnology
Optomec
Mecuris
Fluicell
BigRep
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical 3D Bioprinting Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 SLA
1.2.3 FDM
1.2.4 LOM
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medical 3D Bioprinting Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Device Manufacturers
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medical 3D Bioprinting Market Perspective (2017-2028)
2.2 Medical 3D Bioprinting Growth Trends by Region
2.2.1 Medical 3D Bioprinting Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medical 3D Bioprinting Historic Market Size by Region (2017-2022)
2.2.3 Medical 3D Bioprinting Forecasted Market Size by Region (2023-2028)
2.3 Medical 3D Bioprinting Market Dynamics
2.3.1 Medical 3D Bioprinting Industry Trends
2.3.2 Medical 3D Bioprinting Market Drivers
2.3.3 Medical 3D Bioprinting Market Challenges
2.3.4 Medical 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical 3D Bioprinting Players by Revenue
3.1.1 Global Top Medical 3D Bioprinting Players by Revenue (2017-2022)
3.1.2 Global Medical 3D Bioprinting Revenue Market Share by Players (2017-2022)
3.2 Global Medical 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical 3D Bioprinting Revenue
3.4 Global Medical 3D Bioprinting Market Concentration Ratio
3.4.1 Global Medical 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical 3D Bioprinting Revenue in 2021
3.5 Medical 3D Bioprinting Key Players Head office and Area Served
3.6 Key Players Medical 3D Bioprinting Product Solution and Service
3.7 Date of Enter into Medical 3D Bioprinting Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical 3D Bioprinting Breakdown Data by Type
4.1 Global Medical 3D Bioprinting Historic Market Size by Type (2017-2022)
4.2 Global Medical 3D Bioprinting Forecasted Market Size by Type (2023-2028)
5 Medical 3D Bioprinting Breakdown Data by Application
5.1 Global Medical 3D Bioprinting Historic Market Size by Application (2017-2022)
5.2 Global Medical 3D Bioprinting Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medical 3D Bioprinting Market Size (2017-2028)
6.2 North America Medical 3D Bioprinting Market Size by Type
6.2.1 North America Medical 3D Bioprinting Market Size by Type (2017-2022)
6.2.2 North America Medical 3D Bioprinting Market Size by Type (2023-2028)
6.2.3 North America Medical 3D Bioprinting Market Share by Type (2017-2028)
6.3 North America Medical 3D Bioprinting Market Size by Application
6.3.1 North America Medical 3D Bioprinting Market Size by Application (2017-2022)
6.3.2 North America Medical 3D Bioprinting Market Size by Application (2023-2028)
6.3.3 North America Medical 3D Bioprinting Market Share by Application (2017-2028)
6.4 North America Medical 3D Bioprinting Market Size by Country
6.4.1 North America Medical 3D Bioprinting Market Size by Country (2017-2022)
6.4.2 North America Medical 3D Bioprinting Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medical 3D Bioprinting Market Size (2017-2028)
7.2 Europe Medical 3D Bioprinting Market Size by Type
7.2.1 Europe Medical 3D Bioprinting Market Size by Type (2017-2022)
7.2.2 Europe Medical 3D Bioprinting Market Size by Type (2023-2028)
7.2.3 Europe Medical 3D Bioprinting Market Share by Type (2017-2028)
7.3 Europe Medical 3D Bioprinting Market Size by Application
7.3.1 Europe Medical 3D Bioprinting Market Size by Application (2017-2022)
7.3.2 Europe Medical 3D Bioprinting Market Size by Application (2023-2028)
7.3.3 Europe Medical 3D Bioprinting Market Share by Application (2017-2028)
7.4 Europe Medical 3D Bioprinting Market Size by Country
7.4.1 Europe Medical 3D Bioprinting Market Size by Country (2017-2022)
7.4.2 Europe Medical 3D Bioprinting Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical 3D Bioprinting Market Size (2017-2028)
8.2 Asia-Pacific Medical 3D Bioprinting Market Size by Type
8.2.1 Asia-Pacific Medical 3D Bioprinting Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Medical 3D Bioprinting Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Medical 3D Bioprinting Market Share by Type (2017-2028)
8.3 Asia-Pacific Medical 3D Bioprinting Market Size by Application
8.3.1 Asia-Pacific Medical 3D Bioprinting Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Medical 3D Bioprinting Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Medical 3D Bioprinting Market Share by Application (2017-2028)
8.4 Asia-Pacific Medical 3D Bioprinting Market Size by Region
8.4.1 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medical 3D Bioprinting Market Size (2017-2028)
9.2 Latin America Medical 3D Bioprinting Market Size by Type
9.2.1 Latin America Medical 3D Bioprinting Market Size by Type (2017-2022)
9.2.2 Latin America Medical 3D Bioprinting Market Size by Type (2023-2028)
9.2.3 Latin America Medical 3D Bioprinting Market Share by Type (2017-2028)
9.3 Latin America Medical 3D Bioprinting Market Size by Application
9.3.1 Latin America Medical 3D Bioprinting Market Size by Application (2017-2022)
9.3.2 Latin America Medical 3D Bioprinting Market Size by Application (2023-2028)
9.3.3 Latin America Medical 3D Bioprinting Market Share by Application (2017-2028)
9.4 Latin America Medical 3D Bioprinting Market Size by Country
9.4.1 Latin America Medical 3D Bioprinting Market Size by Country (2017-2022)
9.4.2 Latin America Medical 3D Bioprinting Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical 3D Bioprinting Market Size (2017-2028)
10.2 Middle East & Africa Medical 3D Bioprinting Market Size by Type
10.2.1 Middle East & Africa Medical 3D Bioprinting Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Medical 3D Bioprinting Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Medical 3D Bioprinting Market Share by Type (2017-2028)
10.3 Middle East & Africa Medical 3D Bioprinting Market Size by Application
10.3.1 Middle East & Africa Medical 3D Bioprinting Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Medical 3D Bioprinting Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Medical 3D Bioprinting Market Share by Application (2017-2028)
10.4 Middle East & Africa Medical 3D Bioprinting Market Size by Country
10.4.1 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3D Systems
11.1.1 3D Systems Company Details
11.1.2 3D Systems Business Overview
11.1.3 3D Systems Medical 3D Bioprinting Introduction
11.1.4 3D Systems Revenue in Medical 3D Bioprinting Business (2017-2022)
11.1.5 3D Systems Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Medical 3D Bioprinting Introduction
11.2.4 GE Healthcare Revenue in Medical 3D Bioprinting Business (2017-2022)
11.2.5 GE Healthcare Recent Developments
11.3 ExOne
11.3.1 ExOne Company Details
11.3.2 ExOne Business Overview
11.3.3 ExOne Medical 3D Bioprinting Introduction
11.3.4 ExOne Revenue in Medical 3D Bioprinting Business (2017-2022)
11.3.5 ExOne Recent Developments
11.4 Electro Optical Systems
11.4.1 Electro Optical Systems Company Details
11.4.2 Electro Optical Systems Business Overview
11.4.3 Electro Optical Systems Medical 3D Bioprinting Introduction
11.4.4 Electro Optical Systems Revenue in Medical 3D Bioprinting Business (2017-2022)
11.4.5 Electro Optical Systems Recent Developments
11.5 Renishaw
11.5.1 Renishaw Company Details
11.5.2 Renishaw Business Overview
11.5.3 Renishaw Medical 3D Bioprinting Introduction
11.5.4 Renishaw Revenue in Medical 3D Bioprinting Business (2017-2022)
11.5.5 Renishaw Recent Developments
11.6 Stratasys
11.6.1 Stratasys Company Details
11.6.2 Stratasys Business Overview
11.6.3 Stratasys Medical 3D Bioprinting Introduction
11.6.4 Stratasys Revenue in Medical 3D Bioprinting Business (2017-2022)
11.6.5 Stratasys Recent Developments
11.7 EnvisionTEC
11.7.1 EnvisionTEC Company Details
11.7.2 EnvisionTEC Business Overview
11.7.3 EnvisionTEC Medical 3D Bioprinting Introduction
11.7.4 EnvisionTEC Revenue in Medical 3D Bioprinting Business (2017-2022)
11.7.5 EnvisionTEC Recent Developments
11.8 Cyfuse Biomedical
11.8.1 Cyfuse Biomedical Company Details
11.8.2 Cyfuse Biomedical Business Overview
11.8.3 Cyfuse Biomedical Medical 3D Bioprinting Introduction
11.8.4 Cyfuse Biomedical Revenue in Medical 3D Bioprinting Business (2017-2022)
11.8.5 Cyfuse Biomedical Recent Developments
11.9 Formlabs
11.9.1 Formlabs Company Details
11.9.2 Formlabs Business Overview
11.9.3 Formlabs Medical 3D Bioprinting Introduction
11.9.4 Formlabs Revenue in Medical 3D Bioprinting Business (2017-2022)
11.9.5 Formlabs Recent Developments
11.10 Organovo Holdings
11.10.1 Organovo Holdings Company Details
11.10.2 Organovo Holdings Business Overview
11.10.3 Organovo Holdings Medical 3D Bioprinting Introduction
11.10.4 Organovo Holdings Revenue in Medical 3D Bioprinting Business (2017-2022)
11.10.5 Organovo Holdings Recent Developments
11.11 Allevi
11.11.1 Allevi Company Details
11.11.2 Allevi Business Overview
11.11.3 Allevi Medical 3D Bioprinting Introduction
11.11.4 Allevi Revenue in Medical 3D Bioprinting Business (2017-2022)
11.11.5 Allevi Recent Developments
11.12 Advanced Solutions
11.12.1 Advanced Solutions Company Details
11.12.2 Advanced Solutions Business Overview
11.12.3 Advanced Solutions Medical 3D Bioprinting Introduction
11.12.4 Advanced Solutions Revenue in Medical 3D Bioprinting Business (2017-2022)
11.12.5 Advanced Solutions Recent Developments
11.13 Aspect Biosystems
11.13.1 Aspect Biosystems Company Details
11.13.2 Aspect Biosystems Business Overview
11.13.3 Aspect Biosystems Medical 3D Bioprinting Introduction
11.13.4 Aspect Biosystems Revenue in Medical 3D Bioprinting Business (2017-2022)
11.13.5 Aspect Biosystems Recent Developments
11.14 CELLINK
11.14.1 CELLINK Company Details
11.14.2 CELLINK Business Overview
11.14.3 CELLINK Medical 3D Bioprinting Introduction
11.14.4 CELLINK Revenue in Medical 3D Bioprinting Business (2017-2022)
11.14.5 CELLINK Recent Developments
11.15 GeSiM
11.15.1 GeSiM Company Details
11.15.2 GeSiM Business Overview
11.15.3 GeSiM Medical 3D Bioprinting Introduction
11.15.4 GeSiM Revenue in Medical 3D Bioprinting Business (2017-2022)
11.15.5 GeSiM Recent Developments
11.16 Bio3D Technologies
11.16.1 Bio3D Technologies Company Details
11.16.2 Bio3D Technologies Business Overview
11.16.3 Bio3D Technologies Medical 3D Bioprinting Introduction
11.16.4 Bio3D Technologies Revenue in Medical 3D Bioprinting Business (2017-2022)
11.16.5 Bio3D Technologies Recent Developments
11.17 Regenovo Biotechnology
11.17.1 Regenovo Biotechnology Company Details
11.17.2 Regenovo Biotechnology Business Overview
11.17.3 Regenovo Biotechnology Medical 3D Bioprinting Introduction
11.17.4 Regenovo Biotechnology Revenue in Medical 3D Bioprinting Business (2017-2022)
11.17.5 Regenovo Biotechnology Recent Developments
11.18 Optomec
11.18.1 Optomec Company Details
11.18.2 Optomec Business Overview
11.18.3 Optomec Medical 3D Bioprinting Introduction
11.18.4 Optomec Revenue in Medical 3D Bioprinting Business (2017-2022)
11.18.5 Optomec Recent Developments
11.19 Mecuris
11.19.1 Mecuris Company Details
11.19.2 Mecuris Business Overview
11.19.3 Mecuris Medical 3D Bioprinting Introduction
11.19.4 Mecuris Revenue in Medical 3D Bioprinting Business (2017-2022)
11.19.5 Mecuris Recent Developments
11.20 Fluicell
11.20.1 Fluicell Company Details
11.20.2 Fluicell Business Overview
11.20.3 Fluicell Medical 3D Bioprinting Introduction
11.20.4 Fluicell Revenue in Medical 3D Bioprinting Business (2017-2022)
11.20.5 Fluicell Recent Developments
11.21 BigRep
11.21.1 BigRep Company Details
11.21.2 BigRep Business Overview
11.21.3 BigRep Medical 3D Bioprinting Introduction
11.21.4 BigRep Revenue in Medical 3D Bioprinting Business (2017-2022)
11.21.5 BigRep Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の医療用3Dバイオプリンティング市場インサイト及び予測（SLA、FDM、LOM、その他）(Global Medical 3D Bioprinting Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 3D細胞培養＆3Dバイオプリンティングのグローバル市場展望 2023年-2029年：3D細胞培養、3Dバイオプリンティング
  • バイオプリンティングインクのグローバル市場予測2023-2029
  • 医療用ドローンのグローバル市場2023年：固定翼ドローン、回転翼ドローン
  • 世界の医療用救急キャビネット市場インサイト及び予測（移動式医療緊急キャビネット、固定式医療緊急キャビネット）
  • 世界の副鼻腔炎治療薬市場インサイト及び予測（副腎皮質ステロイド、生理食塩水点鼻薬、充血除去剤、抗生物質、その他）